INTS (STOCKS)
Intensity Therapeutics, Inc. Common stock
$4.160000
+0.540000 (+14.92%)
Prev close: $3.620000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Lewis H. Bender
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $10.73M
- Employees
- 16
- P/E (TTM)
- -0.55
- P/B (TTM)
- 0.92
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
8
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.96 | $-1.11 | +0.1467 | +13.26% |
|
Dec 2025 (Q4)
|
$-1.31 | $-1.28 | -0.0350 | -2.75% |
|
Sep 2025 (Q3)
|
$-1.50 | $-2.23 | +0.7313 | +32.77% |
|
Jun 2025 (Q2)
|
$-3.25 | $-5.04 | +1.7863 | +35.47% |
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $11.10M |
| Research and Development | $5.79M |
| Other Operating Expenses | $5.31M |
| Operating Income/Loss | -$11.10M |
| Income/Loss From Continuing Operations After Tax | -$10.69M |
| Income/Loss From Continuing Operations Before Tax | -$10.69M |
| Net Income/Loss | -$10.69M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$10.69M |
| Net Income/Loss Available To Common Stockholders, Basic | -$10.69M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$9.38 |
| Diluted Earnings Per Share | -$9.38 |
| Basic Average Shares | 40,004,335 |
| Diluted Average Shares | 40,004,335 |
| Assets | $12.29M |
| Current Assets | $10.91M |
| Cash | $10.20M |
| Prepaid Expenses | $661.00K |
| Other Current Assets | $45.00K |
| Noncurrent Assets | $1.39M |
| Liabilities | $2.31M |
| Current Liabilities | $2.24M |
| Accounts Payable | $636.00K |
| Wages | $917.00K |
| Other Current Liabilities | $689.00K |
| Noncurrent Liabilities | $70.00K |
| Equity | $9.98M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $9.98M |
| Liabilities And Equity | $12.29M |
| Net Cash Flow From Operating Activities | -$9.07M |
| Net Cash Flow From Operating Activities, Continuing | -$9.07M |
| Net Cash Flow From Investing Activities | -$9.32M |
| Net Cash Flow From Investing Activities, Continuing | -$9.32M |
| Net Cash Flow From Financing Activities | $18.39M |
| Net Cash Flow From Financing Activities, Continuing | $18.39M |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | -$10.69M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$10.69M |
| Other Comprehensive Income/Loss | $0.00 |